Cory Sago is co-founder & CEO of Amplitude Therapeutics, a seed-stage company developing differentiated RNA medicines and vaccines enabled by their trans-amplifying RNA platform. Previously, Cory co-founded and was CTO of Guide Therapeutics which advanced a novel, high-throughput platform to discover LNPs for RNA delivery variety of tissues including the liver, immune cells, and HSCs. GuideTx was acquired by Beam Therapeutics in 2021, where Cory served as Head of LNP Discovery. Cory received his PhD in Biomedical Engineering from Georgia Tech and Emory University.